These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9021005)

  • 1. Restless legs syndrome and paroxetine.
    Sanz-Fuentenebro FJ; Huidobro A; Tejadas-Rivas A
    Acta Psychiatr Scand; 1996 Dec; 94(6):482-4. PubMed ID: 9021005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome following the combined use of quetiapine and paroxetine.
    Chou KJ; Chen PY; Huang MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1139-40. PubMed ID: 20470847
    [No Abstract]   [Full Text] [Related]  

  • 3. Restless legs syndrome associated with the combined use of duloxetine plus paroxetine.
    Nikolaou KN; Michopoulos I; Douzenis A; Papazahos C; Papageorgiou C; Gournellis R
    J Clin Psychopharmacol; 2015 Jun; 35(3):345-6. PubMed ID: 25815756
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal after discontinuation of paroxetine.
    Arya DK
    Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
    [No Abstract]   [Full Text] [Related]  

  • 5. Akathisia: a review and case report following paroxetine treatment.
    Baldassano CF; Truman CJ; Nierenberg A; Ghaemi SN; Sachs GS
    Compr Psychiatry; 1996; 37(2):122-4. PubMed ID: 8654061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mianserin and restless legs.
    Markkula J; Lauerma H
    Int Clin Psychopharmacol; 1997 Jan; 12(1):53-8. PubMed ID: 9179635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Narcoleptic syndrome as a possible side effect of paroxetine].
    Alonso H; Ortí-Pareja M; Jiménez-Jiménez FJ
    Rev Neurol; 2004 Dec 1-15; 39(11):1092. PubMed ID: 15597274
    [No Abstract]   [Full Text] [Related]  

  • 8. [SSRI-induced akathesia].
    Hofmann M; Vidoni F
    Psychiatr Prax; 1996 May; 23(3):143-4. PubMed ID: 8711007
    [No Abstract]   [Full Text] [Related]  

  • 9. Restless legs syndrome associated with the combined use of quetiapine and venlafaxine.
    Michopoulos I; Ferentinos P; Oulis P; Gournellis R
    J Clin Psychopharmacol; 2014 Feb; 34(1):159-61. PubMed ID: 24135842
    [No Abstract]   [Full Text] [Related]  

  • 10. [Paroxetine-induced neuroleptic malignant syndrome].
    Heinemann F; Assion HJ; Hermes G; Ehrlich M
    Nervenarzt; 1997 Aug; 68(8):664-6. PubMed ID: 9380213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine treatment for paroxetine-induced restless leg syndrome.
    Oztürk O; Eraslan D; Kumral E
    Gen Hosp Psychiatry; 2006; 28(3):264-5. PubMed ID: 16675374
    [No Abstract]   [Full Text] [Related]  

  • 12. Antidepressant-related hypomania in a patient with premenstrual dysphoric disorder.
    Hsiao MC; Liu CY
    J Clin Psychopharmacol; 2002 Oct; 22(5):534-5. PubMed ID: 12352284
    [No Abstract]   [Full Text] [Related]  

  • 13. Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy.
    Diler RS; Tamam L; Avci A
    J Clin Psychopharmacol; 2000 Oct; 20(5):586-7. PubMed ID: 11001250
    [No Abstract]   [Full Text] [Related]  

  • 14. Putting GlaxoSmithKline to the test over paroxetine.
    Doshi P
    BMJ; 2013 Nov; 347():f6754. PubMed ID: 24222673
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous vasculitis induced by paroxetine.
    Margolese HC; Chouinard G; Beauclair L; Rubino M
    Am J Psychiatry; 2001 Mar; 158(3):497. PubMed ID: 11230000
    [No Abstract]   [Full Text] [Related]  

  • 16. Paroxetine in a case of psychogenic pruritus and neurotic excoriations.
    Biondi M; Arcangeli T; Petrucci RM
    Psychother Psychosom; 2000; 69(3):165-6. PubMed ID: 10773782
    [No Abstract]   [Full Text] [Related]  

  • 17. Odd odds.
    Andrade C
    J Clin Psychiatry; 2011 Nov; 72(11):1558-9; author reply 1559. PubMed ID: 22127198
    [No Abstract]   [Full Text] [Related]  

  • 18. Neonatal convulsions secondary to paroxetine withdrawal.
    Ahmed M; Parameshwaran A; Swamy P
    J Pak Med Assoc; 2007 Mar; 57(3):162. PubMed ID: 17432029
    [No Abstract]   [Full Text] [Related]  

  • 19. Exacerbation of extrapyramidal symptoms with paroxetine.
    Arya DK; McKenzie J; Worrall N
    Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressant exacerbation of spasticity.
    Stolp-Smith KA; Wainberg MC
    Arch Phys Med Rehabil; 1999 Mar; 80(3):339-42. PubMed ID: 10084445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.